DMC Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,349
| Closed | -$402K | – | 134 |
|
|
2024
Q2 | $402K | Sell |
4,349
-398
| -8% | -$36.8K | 0.34% | 85 |
|
|
2024
Q1 | $454K | Buy |
4,747
+1,186
| +33% | +$113K | 0.39% | 82 |
|
|
2023
Q4 | $272K | Buy |
3,561
+154
| +5% | +$11.7K | 0.26% | 105 |
|
|
2023
Q3 | $236K | Sell |
3,407
-85
| -2% | -$5.89K | 0.22% | 105 |
|
|
2023
Q2 | $329K | Sell |
3,492
-17
| -0.5% | -$1.6K | 0.33% | 90 |
|
|
2023
Q1 | $288K | Buy |
3,509
+746
| +27% | +$61.3K | 0.29% | 99 |
|
|
2022
Q4 | $205K | Sell |
2,763
-35
| -1% | -$2.6K | 0.23% | 110 |
|
|
2022
Q3 | $239K | Buy |
2,798
+178
| +7% | +$15.2K | 0.29% | 93 |
|
|
2022
Q2 | $253K | Buy |
2,620
+41
| +2% | +$3.96K | 0.3% | 89 |
|
|
2022
Q1 | $305K | Sell |
2,579
-1,957
| -43% | -$231K | 0.34% | 81 |
|
|
2021
Q4 | $462K | Buy |
+4,536
| New | +$462K | 0.4% | 74 |
|